Bee Vectoring - BEVVF STOCK NEWS

Bee Vectoring Technologies International Inc. announces Agrobío SL's trials of BVT's natural precision agriculture system in the EU-funded ADOPT-IPM project. The trial aims to optimize Integrated Pest Management tools and foster stakeholder adoption.

Bee Vectoring Technologies International Inc. announces major multi-national grower conducting demonstration trials in Mexico with BVT's proprietary Vectorite with CR-7 biological fungicide and natural precision agriculture system. The grower is a key producer of blueberries, raspberries, blackberries, and table grapes with over 5,000 hectares worldwide. The trials, staggered to the start of bloom time for each berry crop, are evaluating yield performance and percentage of fruit spoilage with BVT and the grower standard applied versus the grower standard used alone. Geographic expansion is a key element in BVT's ongoing corporate expansion strategy, with a focus on building and expanding strategic relationships with Mexican growers.

Bee Vectoring Technologies International Inc. announces that South African agricultural technology company MBFi has started trials of BVT products in South Africa. The trials will evaluate BVT's patented bee vectoring dispenser for honeybees with proprietary Vectorite powder, comparing it with traditional spray applications. The trials will cover various crops, including macadamias, avocados, apples, strawberries, blueberries, cherries, sunflowers, and canola. If successful, this partnership could significantly increase BVT's market reach and revenue stream in South Africa.

Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) has entered into debt settlement agreements to settle outstanding cash payments owed to certain creditors totaling $1,130,000. The Company has agreed to issue an aggregate of 18,833,334 Common shares at a deemed price of $0.06 per Common share.

Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) has entered into a secured loan agreement with two capital firms for a loan of up to CAD $1 million. The loan will be funded in tranches of $100,000 at the Company's discretion, with each tranche being secured and evidenced by promissory notes. The Company reserves the right to choose the method of settlement for each note within a two-year period, either through cash repayment or issuing common shares. The loan carries an annualized interest rate of 15% and will be used to fund the Company's ongoing growth strategy in the agricultural space, research and development, marketing services, and general working capital purposes.

Bee Vectoring Technologies International Inc. (BEE) has closed a debt settlement agreement by issuing 2,765,138 common shares at a deemed price of $0.06 per share to satisfy an outstanding cash payment of $165,908.34 for legal fees.

Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) announces a debt settlement agreement to settle outstanding cash payments owed to a creditor for legal fees. The Company will issue 2,765,138 Common shares at a deemed price of $0.06 per Common share.

Bee Vectoring Technologies International Inc. will be exploring partnership opportunities at ABIM 2023. The conference is a global meeting place for the biocontrol industry, with over 1,700 participants from more than 50 nations. The CEO of BVT, Ashish Malik, is excited about the chance to connect with important players in the industry and progress BVT's expansion strategy. The event will also focus on facilitating the transformation to sustainable agriculture.

Bee Vectoring Technologies announces first sales order of Clonostachys rosea CR-7 microbe for foliar application market, in a groundbreaking deal with BioSafe Systems. This marks BVT's entry into the foliar business and expands their market. BVT will receive a royalty for every BioSafe sale. The deal confirms the success of BVT's strategy to expand business through channel partners and enables them to scale growth and expand market share quickly.